PT  - JOURNAL ARTICLE
AU  - Claire L Gordon
AU  - Jason A Trubiano
AU  - Natasha E Holmes
AU  - Kyra YL Chua
AU  - Jeff Feldman
AU  - Greg Young
AU  - Norelle L Sherry
AU  - M Lindsay Grayson
AU  - Jason C Kwong
TI  - Staff to staff transmission as a driver of healthcare worker infections with COVID-19
AID  - 10.1101/2020.12.25.20248824
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.25.20248824
4099  - http://medrxiv.org/content/early/2020/12/30/2020.12.25.20248824.short
4100  - http://medrxiv.org/content/early/2020/12/30/2020.12.25.20248824.full
AB  - Objectives To investigate the COVID-19 infections among staff at our institution and determine the interventions required to prevent subsequent staff infections.Design Retrospective cohort studyParticipants and setting Staff working at a single tertiary referral hospital who returned a positive test result for SARS-CoV-2 between 25 January 2020 and 25 November 2020.Main outcome measures Source of COVID-19 infection.Results Of 45 staff who returned a positive test result for SARS-CoV-2, 19 were determined to be acquired at Austin Health. Fifteen (15/19; 79% [95% CI: 54–94%]) of these were identified through contact tracing and testing following exposures to other infected staff and were presumed to be staff-staff transmission, including 10 healthcare workers (HCWs) linked to a single ward that cared for COVID-19 patients. Investigation of the outbreak identified the staff tearoom as the likely location for transmission, with subsequent reduction in HCW infections and resolution of the outbreak following implementation of enhanced control measures in tearoom facilities. No HCW contacts (0/204; 0% [95% CI: 0–2%]) developed COVID-19 infection following exposure to unrecognised patients with COVID-19.Conclusions Unrecognised infections among staff may be a significant driver of HCW infections in healthcare settings. Control measures should be implemented to prevent acquisition from other staff as well as patient-staff transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCLG (GNT1160963), JAT (GNT1139902) and JCK (GNT1142613) are supported by Early Career Fellowships from the National Health and Medical Research Council (NHMRC), Australia. This study was undertaken independently of the NHMRC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval and oversight for this study was provided by the Austin Health Office for Research (CD 20/011 and Audit/20/Austin/169).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/a